Pain-Drug Rights Sold

Meanwhile, Zogenix announces sale of painkiller.

Alkermes PLC said it is selling its Georgia manufacturing facility and global rights to its experimental pain treatment to Recro Pharma Inc., as the Irish specialty-pharmaceutical company seeks to focus on its pipeline of central-nervous-system treatments. Alkermes said it will receive a $50 million initial payment and up to $120 million in milestone payments.

READ FULL ARTICLE Curated publisher From The Wall Street Journal